Results 31 to 40 of about 8,977,908 (300)

Power-law models for infectious disease spread [PDF]

Annals of Applied Statistics 2014, Vol. 8, No. 3, 1612-1639, 2013
Short-time human travel behaviour can be described by a power law with respect to distance. We incorporate this information in space-time models for infectious disease surveillance data to better capture the dynamics of disease spread. Two previously established model classes are extended, which both decompose disease risk additively into endemic and ...
arxiv   +1 more source

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

MMWR. Morbidity and mortality weekly report, 2017
Use of eculizumab (Soliris, Alexion Pharmaceuticals), a terminal complement inhibitor, is associated with a 1,000-fold to 2,000-fold increased incidence of meningococcal disease (1).
L. McNamara, Nadav Topaz, Xin Wang, S. Hariri, L. Fox, Jessica R Macneil   +5 more
semanticscholar   +2 more sources

Meningococcemia in a vaccinated child receiving eculizumab and review of the literature

The Turkish Journal of Pediatrics, 2023
Background. Atypical hemolytic uremic syndrome (aHUS) is a rare and severe disease characterized by uncontrolled activation and dysregulation of the alternative complement pathway and development of thrombotic microangiopathy. Eculizumab, which is
Diana Üçkardeş, Nilüfer Göknar, Nurhan Kasap, Emre Keleşoğlu, Mustafa Arga, Cengiz Candan   +5 more
doaj   +1 more source

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations

Expert Review of Vaccines, 2018
Introduction: The 2018 Global Meningococcal Initiative (GMI) meeting focused on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and protection strategies worldwide, with emphasis on emerging antibiotic resistance and protection ...
R. Acevedo, Xilian Bai, R. Borrow, D. Caugant, J. Carlos, M. Ceyhan, H. Christensen, Yanet Climent, P. De Wals, E. Dinleyici, G. Echániz-Avilés, A. Hakawi, H. Kamiya, A. Karachaliou, J. Lucidarme, S. Meiring, K. Mironov, M. Sáfadi, Z. Shao, Vinny Smith, R. Steffen, Bianca Stenmark, M. Taha, C. Trotter, J. Vázquez, B. Zhu   +25 more
semanticscholar   +1 more source

Recommendations for the use of meningococcal vaccines in South Africa

Southern African Journal of Infectious Diseases, 2017
Background: Although meningococcal disease (MD) incidence in South Africa is low, Neisseria meningitidis (NM) causes severe disease that is often life-threatening and can cause long-term disabilities.
Susan Meiring, Gregory Hussey, Prakash Jeena, Salim Parker, Anne von Gottberg   +4 more
doaj   +1 more source

Meningococcal vaccines in China

Human Vaccines & Immunotherapeutics, 2021
Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines.
Yinghua Xu, Yanan Li, Shanshan Wang, Maoguang Li, Miao Xu, Qiang Ye   +5 more
doaj   +1 more source

Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers

Infectious Disease and Therapy, 2018
IntroductionInvasive meningococcal disease (IMD, septicaemia and/or meningitis) has a severe acute and long-term burden: 5–10% of patients die within 48 h, and long-term sequelae have been reported in 10–20% of survivors.
K. Olbrich, D. Müller, S. Schumacher, E. Beck, K. Meszaros, F. Koerber   +5 more
semanticscholar   +1 more source

Clinical Case of Repeated Generalized Infection and Meningitis in Immunocompetent Child

Педиатрическая фармакология, 2021
Background. Meningococcal disease is socially significant, deadly infectious disease characterized by severe and unpredictable course. Clinical case description.
Mariya S. Vedyashkina, Anna M. Dubrovsky, Olga V. Lopatina, Svetlana V. Rychkova   +3 more
doaj   +1 more source

University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013–2018

Emerging Infectious Diseases, 2019
We reviewed university-based outbreaks of meningococcal disease caused by serogroup B and vaccination responses in the United States in the years following serogroup B meningococcal (MenB) vaccine availability.
Heidi M. Soeters, L. McNamara, Amy E. Blain, M. Whaley, Jessica R Macneil, S. Hariri, Sarah A Mbaeyi   +6 more
semanticscholar   +1 more source

Treatment of Meningococcal Disease [PDF]

Journal of Adolescent Health, 2016
Meningococcal disease is a life-threatening infection that may progress rapidly, even after appropriate treatment has commenced. Early suspicion of the diagnosis is vital so that parenteral antibiotic treatment can be administered as soon as possible to reduce the complications of infection.
openaire   +3 more sources